Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NIH 4OTHER 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 32Lymphoma, Follicular 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Lymphoma, B-Cell, Marginal Zone 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1

Interventions

Etoposide 2ibritumomab tiuxetan 1Vincristine 1Rituximab 1Radiotherapy 1Radioimmunotherapy 1Procarbazine 1Prednisone 1Methylprednisolone 1Lomustine 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, AIDS-Related × Rituximab × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡